Literature DB >> 20559766

Does increased rate of limb-sparing surgery affect survival in osteosarcoma?

Miguel A Ayerza1, Germán L Farfalli, Luis Aponte-Tinao, D Luis Muscolo.   

Abstract

BACKGROUND: The emergence of limb salvage surgery as an option for patients with osteosarcoma is attributable to preoperative chemotherapy and advancements in musculoskeletal imaging and surgical technique. While the indications for limb salvage have greatly expanded it is unclear whether limb salvage affects overall survival. QUESTIONS/PURPOSES: We asked whether over the past three decades limb-sparing procedures in high-grade osteosarcoma had increased, and whether this affected survival and ultimate amputation.
METHODS: We retrospectively reviewed 251 patients with high-grade osteosarcoma treated from 1980 to 2004 with a multidisciplinary approach, including neoadjuvant chemotherapy. We compared survival rates, limb-salvage treatment, and amputation after limb-sparing procedure during three different periods of time. Fifty-three patients were treated from 1980 to 1989, 97 from 1990 to 1999, and 101 from 2000 to 2004. Thirty-seven patients were treated with primary amputations and 214 with primary limb salvage.
RESULTS: The 5-year survival rate in the first period was 36%, whereas in the 1990 s, it was 60% and 67% from 2000-2004. Limb salvage surgery rate in the 1980s was 53% (28 of 53), whereas in the 1990 s, it was 91% (88 of 97) and 97% from 2000-2004 (98 of 101). In the limb salvage group, 22 of the 214 patients (10%) required secondary amputation; the final limb salvage rate in the first period was 36% (19 of 53), whereas in the 1990 s, it was 81% (79 of 97) and 93% from 2000-2004 (94 of 101).
CONCLUSIONS: Patients with osteosarcoma treated in the last two periods had higher rates of limb salvage treatment and survival, with lower secondary amputation.

Entities:  

Mesh:

Year:  2010        PMID: 20559766      PMCID: PMC2947695          DOI: 10.1007/s11999-010-1423-4

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  22 in total

1.  Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy.

Authors:  G Bacci; S Ferrari; S Lari; M Mercuri; D Donati; A Longhi; C Forni; F Bertoni; M Versari; E Pignotti
Journal:  J Bone Joint Surg Br       Date:  2002-01

2.  Limb-sparing surgery preserves more function than amputation: a Scandinavian sarcoma group study of 118 patients.

Authors:  L H Aksnes; H C F Bauer; N L Jebsen; G Follerås; C Allert; G S Haugen; K S Hall
Journal:  J Bone Joint Surg Br       Date:  2008-06

3.  Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol.

Authors:  G Bacci; S Ferrari; A Longhi; C Forni; F Bertoni; N Fabbri; M Zavatta; M Versari
Journal:  J Chemother       Date:  2001-02       Impact factor: 1.714

4.  Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur.

Authors:  M A Simon; M A Aschliman; N Thomas; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1986-12       Impact factor: 5.284

5.  Osteogenic sarcoma. A study of six hundred cases.

Authors:  D C Dahlin; M B Coventry
Journal:  J Bone Joint Surg Am       Date:  1967-01       Impact factor: 5.284

6.  Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.

Authors:  F Eilber; A Giuliano; J Eckardt; K Patterson; S Moseley; J Goodnight
Journal:  J Clin Oncol       Date:  1987-01       Impact factor: 44.544

7.  Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.

Authors:  Douglas S Hawkins; Carola A S Arndt
Journal:  Cancer       Date:  2003-12-01       Impact factor: 6.860

8.  Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.

Authors:  Allen M Goorin; Douglas J Schwartzentruber; Meenakshi Devidas; Mark C Gebhardt; Alberto G Ayala; Michael B Harris; Lee J Helman; Holcombe E Grier; Michael P Link
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

9.  Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.

Authors:  G Rosen; R C Marcove; B Caparros; A Nirenberg; C Kosloff; A G Huvos
Journal:  Cancer       Date:  1979-06       Impact factor: 6.860

10.  A system of staging musculoskeletal neoplasms.

Authors:  W F Enneking
Journal:  Clin Orthop Relat Res       Date:  1986-03       Impact factor: 4.176

View more
  25 in total

1.  [Primary malignant bone tumors].

Authors:  R von Eisenhart-Rothe; A Toepfer; M Salzmann; J Schauwecker; H Gollwitzer; H Rechl
Journal:  Orthopade       Date:  2011-12       Impact factor: 1.087

2.  Does limb-salvage surgery offer patients better quality of life and functional capacity than amputation?

Authors:  Farbod Malek; Jeremy S Somerson; Shannon Mitchel; Ronald P Williams
Journal:  Clin Orthop Relat Res       Date:  2012-07       Impact factor: 4.176

3.  What Is the Expected Learning Curve in Computer-assisted Navigation for Bone Tumor Resection?

Authors:  Germán L Farfalli; José I Albergo; Lucas E Ritacco; Miguel A Ayerza; Federico E Milano; Luis A Aponte-Tinao
Journal:  Clin Orthop Relat Res       Date:  2016-02-25       Impact factor: 4.176

4.  Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison.

Authors:  Tracy A Marko; Brandon J Diessner; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2016-02-29       Impact factor: 3.167

5.  Physeal distraction for joint preservation in malignant metaphyseal bone tumors in children.

Authors:  Michael Betz; Charles E Dumont; Bruno Fuchs; G Ulrich Exner
Journal:  Clin Orthop Relat Res       Date:  2011-12-28       Impact factor: 4.176

6.  Survival, recurrence, and function after epiphyseal preservation and allograft reconstruction in osteosarcoma of the knee.

Authors:  Luis Aponte-Tinao; Miguel A Ayerza; D Luis Muscolo; Germán L Farfalli
Journal:  Clin Orthop Relat Res       Date:  2014-10-29       Impact factor: 4.176

Review 7.  Amputation Versus Limb-Salvage Surgery in Patients with Osteosarcoma: A Meta-analysis.

Authors:  Gang Han; Wen-Zhi Bi; Meng Xu; Jin-Peng Jia; Yan Wang
Journal:  World J Surg       Date:  2016-08       Impact factor: 3.352

Review 8.  Common musculoskeletal tumors of childhood and adolescence.

Authors:  Carola A S Arndt; Peter S Rose; Andrew L Folpe; Nadia N Laack
Journal:  Mayo Clin Proc       Date:  2012-05       Impact factor: 7.616

9.  The Current and Future Therapies for Human Osteosarcoma.

Authors:  Joseph D Lamplot; Sahitya Denduluri; Jiaqiang Qin; Ruidong Li; Xing Liu; Hongyu Zhang; Xiang Chen; Ning Wang; Abdullah Pratt; Wei Shui; Xiaoji Luo; Guoxin Nan; Zhong-Liang Deng; Jinyong Luo; Rex C Haydon; Tong-Chuan He; Hue H Luu
Journal:  Curr Cancer Ther Rev       Date:  2013-02

10.  Short Term Complications and Functional Results of Sarcoma Limb Salvage Surgeries.

Authors:  Mohammad Gharehdaghi; Mohammad Hassani; Ali Parsa; Farzad Omidikashani; Lida Jarrahi; Rahim Hosseini
Journal:  Arch Bone Jt Surg       Date:  2019-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.